课题基金 / 基金详情

Evading innate immunity during human cytomegalovirus latency

Evading innate immunity during human cytomegalovirus latency
在人类巨细胞病毒潜伏期逃避先天免疫
批准号:
10392335
负责人:
ROBERT F KALEJTA
金额:
$35.58万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-05-02 至 2024-04-30

项目摘要

项目成果

ROBERT F KALEJTA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Innate immunity senses intracellular pathogens and induces the expression of cellular genes with antiviral functions. Most if not all viruses encode proteins that inhibit innate immunity during productive, lytic infections, but the role of innate immunity during viral latency is underappreciated and understudied. Latency permits human cytomegalovirus (HCMV) to colonize its hosts for their lifetime by avoiding immune detection and clearance. During latency, the levels of lytic (productive) phase HCMV proteins such as IE1 (Immediate Early 1) are kept extremely low (or completely absent) because the promoter that drives its expression, the Major Immediate Early Promoter (MIEP) is transcriptionally silenced by heterochromatin. IE1 is a transcription factor that promotes progression through the viral lytic phase and is a target of cytotoxic T cells. Therefore, keeping IE1 protein levels low or absent protects latently infected cells from immune surveillance and restricts reactivation events until the proper stimulus is sensed. We published that the viral UL138 protein silences IE1 transcription during latency by inhibiting the recruitment of lysine- specific demethylases (KDMs) to the MIEP that otherwise remove repressive epigenetic histone methylations to activate transcription. Our preliminary data indicates this occurs, in part, through a suppression of cellular innate immune pathways. Here we propose to determine how UL138-mediated evasion of cellular innate immunity contributes to the establishment and maintenance of HCMV latency, with a particular focus on viral epigenetics and the transcriptional silencing of IE1.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
NFκB and Cyclic AMP Response Element Sites Mediate the Valproic Acid and UL138 Responsiveness of the Human Cytomegalovirus Major Immediate Early Enhancer and Promoter.
NFκB 和环 AMP 反应元件位点介导人类巨细胞病毒主要立即早期增强子和启动子的丙戊酸和 UL138 反应性。
DOI: 10.1128/jvi.00029-23
发表时间: 2023
期刊: Journal of virology
影响因子: 5.4
作者: [Albright,EmilyR, Walter,RyanM, Saffert,RyanT, Kalejta,RobertF]
通讯作者: Kalejta,RobertF
DOI: 10.1128/mbio.02267-21
发表时间: 2021-12-21
期刊: mBio
影响因子: 6.4
作者: [Albright ER, Mickelson CK, Kalejta RF]
通讯作者: Kalejta RF
DOI: 10.1128/mbio.02410-20
发表时间: 2020-09-29
期刊: mBio
影响因子: 6.4
作者: [Lyon SM, Yetming KD, Paulus C, Nevels M, Kalejta RF]
通讯作者: Kalejta RF
The Golgi sorting motifs of human cytomegalovirus UL138 are not required for latency maintenance.
人巨细胞病毒 UL138 的高尔基体分选基序不需要维持潜伏期。
DOI: 10.1016/j.virusres.2019.197646
发表时间: 2019
期刊: Virus research
影响因子: 5
作者: [Gelbmann,ChristopherB, Kalejta,RobertF]
通讯作者: Kalejta,RobertF
Deciphering the cell type specific control of HCMV tegument-delivered pp71 subcellular localization
  • 批准号:
    10176409
  • 项目类别:
  • 资助金额:
    $19.43万
  • 财政年份:
    2020
  • 负责人:
    ROBERT F KALEJTA
  • 依托单位:
Transcriptional Control of Human Cytomegalovirus Latency
  • 批准号:
    10370328
  • 项目类别:
  • 资助金额:
    $36.98万
  • 财政年份:
    2018
  • 负责人:
    ROBERT F KALEJTA
  • 依托单位:
Transcriptional Control of Human Cytomegalovirus Latency
  • 批准号:
    9894713
  • 项目类别:
  • 资助金额:
    $36.98万
  • 财政年份:
    2018
  • 负责人:
    ROBERT F KALEJTA
  • 依托单位:
Evading innate immunity during human cytomegalovirus latency
  • 批准号:
    9919503
  • 项目类别:
  • 资助金额:
    $35.58万
  • 财政年份:
    2018
  • 负责人:
    ROBERT F KALEJTA
  • 依托单位:
海外基金